Last reviewed · How we verify
NCT06353230: Prolapse
Comparison of Sclerotherapy Agents Used for Rectal Prolapse Treatment in Children
NA trial testing injection 5% phenol in almond oil in Rectal Prolapse in 93 participants. Completed in 13 April 2021.
14 October 2020
Quick facts
| Lead sponsor | King Edward Medical University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 93 |
| Start date | 15 October 2019 |
| Primary completion | 14 October 2020 |
| Estimated completion | 13 April 2021 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- injection 5% phenol in almond oil
- injection 15% hypertonic saline
- injection 50% dextrose water
Conditions studied
- Rectal Prolapse — all drugs for Rectal Prolapse →
Sponsor
King Edward Medical University
Who can join
Adults 3 to 13, any sex, with Rectal Prolapse. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Introduction Patients with rectal prolapse are treated with injection sclerotherapy, which is the most often used first-line surgical technique. Injection sclerotherapy has a success rate of 90-100% in youngsters, according to certain studies. Objective To compare the outcome of injection sclerotherapy using 5% Phenol in almond oil, 15% hypertonic saline and 50% dextrose water in the treatment of rectal prolapse in children.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06353230
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Rectal Prolapse
Currently open trials in the same condition.
- NCT06245577 — Biological Mesh Versus Synthetic Mesh in Interdisciplinary RRP With SCP · NA · active not recruiting
- NCT05918367 — Multicenter Ventral Mesh Rectopexy Registry Collaborative · recruiting
- NCT04169152 — CAES for Internal Hemorrhoids and Rectal Prolapse · recruiting
- NCT03917056 — Cap-assisted Endoscopic Sclerotherapy for Internal Hemorrhoids and Rectal Prolapse · NA · recruiting
- NCT04013152 — Clinical Database of Colorectal Robotic Surgery · active not recruiting
Other King Edward Medical University trials
Trials by the same sponsor.
- NCT07480447 — Comparison of Pain Reduction in Painful Chronic Wounds With and Without Fat Grafting · NA · not yet recruiting
- NCT07428265 — Comparison of Wound Healing for Diabetic Carbuncle Treated With Incision and Drainage Technique Using Cruciate Incision · NA · recruiting
- NCT07368439 — Effect of Feedback-Based Balance Training on Balance and Gait in Cancer Patients With Chemotherapy-Induced Peripheral Ne · NA · not yet recruiting
- NCT07210424 — Comparative Study on the Post-operative Pain and Other Outcomes of Mesh Fixation With Prolene vs Vicryl vs Skin Staples · not yet recruiting
- NCT07267260 — Evaluating the Efficacy of Vonoprazan in Preventing Post-Endoscopic Variceal Band Ligation Ulcers: A Randomized Controll · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06353230 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by King Edward Medical University
- Last refreshed: 15 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06353230.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing